A joint Schedule 13G filing was
Filed with the SEC on · accession 0002103370-26-000004
RKDA filed a SCHEDULE 13G (schedule 13g) with the SEC on Sep 30, 2026. A joint Schedule 13G filing was submitted regarding beneficial ownership of Arcadia Biosciences (RKDA) common stock. The stock moved -0.2% by the first close after the filing.
A joint Schedule 13G filing was submitted regarding beneficial ownership of Arcadia Biosciences (RKDA) common stock. The filing indicates passive ownership by the reporting persons, with no plans to influence control of the company.
Close before
$0.28
Sep 29, 2026
First close after
-0.25%
$0.28
5 trading days
+6.16%
$0.30
Since filing
-42.64%
$0.16
✦ Ask GOAX AI about this filing — what it means for RKDA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for RKDA?
Click hereRKDA filed a SCHEDULE 13G (SEC filing). A joint Schedule 13G filing was submitted regarding beneficial ownership of Arcadia Biosciences (RKDA) common stock. The filing indicates passive ownership by the reporting persons, with no plans to influence control of the company.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
RKDA closed at $0.28 before the filing and $0.28 on Sep 30, 2026 (-0.25%). Five trading days later: $0.30 (+6.16%).
Get alerts when RKDA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days